Product Information
QC STOMACH RLF 262 MG CHEW TAB is a generic product labeled by Chain Drug Marketing Association, priced at $0.0817 per EA under NDC 83324013030. Its NADAC has been published 87 times since Feb 5, 2025.
Strength
262 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324013030
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M008On Market Since
9/30/2024
Pharmacological Classes
Price Statistics
The NADAC for QC STOMACH RLF 262 MG CHEW TAB has been published 87 times since Feb 5, 2025, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0817 per EA |
|---|---|
| All-time high | $0.0854 (Dec 10, 2025) |
| All-time low | $0.0766 (Feb 5, 2025) |
| 52-week high | $0.0854 |
| 52-week low | $0.0809 |
| Median price | $0.0827 |
| Average price | $0.0824 |
| Largest weekly change | +5.5% (Feb 19, 2025) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Stomach Relief market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Stomach Relief market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bismuth class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC STOMACH RLF 262 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for QC STOMACH RLF 262 MG CHEW TAB, manufactured by Chain Drug Marketing Association, is $0.0817 per EA (NDC 83324013030), effective Sep 30, 2026.
How has the price of QC STOMACH RLF 262 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for QC STOMACH RLF 262 MG CHEW TAB has risen 6.6%. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC STOMACH RLF 262 MG CHEW TAB?
Since Feb 5, 2025, the NADAC for QC STOMACH RLF 262 MG CHEW TAB has ranged from a low of $0.0766 (Feb 5, 2025) to a high of $0.0854 (Dec 10, 2025), with a median of $0.0827 per EA.
Are there cheaper alternatives to QC STOMACH RLF 262 MG CHEW TAB?
No other NADAC-published product currently shares the active ingredient and strength of QC STOMACH RLF 262 MG CHEW TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC STOMACH RLF 262 MG CHEW TAB?
QC STOMACH RLF 262 MG CHEW TAB (NDC 83324013030) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.